相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Implications of Tau Dysregulation in Huntington's Disease and Potential for New Therapeutics
Isaline Mees et al.
JOURNAL OF HUNTINGTONS DISEASE (2023)
Passive immunization against phosphorylated tau improves features of Huntington's disease pathology
Melanie Alpaugh et al.
MOLECULAR THERAPY (2022)
A biological classification of Huntington's disease: the Integrated Staging System
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2022)
What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease
Lukasz Przybyl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cortical microstructural correlates of plasma neurofilament light chain in Huntington's disease
Frederic Sampedro et al.
PARKINSONISM & RELATED DISORDERS (2021)
Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression
Georgia M. Parkin et al.
PARKINSONISM & RELATED DISORDERS (2021)
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
Elisabeth H. Thijssen et al.
NATURE MEDICINE (2020)
Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease
Marta Fernandez-Nogales et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Serum neurofilament light levels in normal aging and their association with morphologic brain changes
Michael Khalil et al.
NATURE COMMUNICATIONS (2020)
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases
Giovanni Palermo et al.
MOLECULAR NEUROBIOLOGY (2020)
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease
Filipe B. Rodrigues et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Targeting Tau to Treat Clinical Features of Huntington's Disease
Maria Masnata et al.
FRONTIERS IN NEUROLOGY (2020)
Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment
Signe Pertou Ringkobing et al.
JOURNAL OF HUNTINGTONS DISEASE (2020)
Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis
Mei Jin et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
Sebastian Palmqvist et al.
EMBO MOLECULAR MEDICINE (2019)
Spectrum of tau pathologies in Huntington's disease
Swikrity Upadhyay Baskota et al.
LABORATORY INVESTIGATION (2019)
Neurofilament light protein in blood predicts regional atrophy in Huntington disease
Eileanoir B. Johnson et al.
NEUROLOGY (2018)
Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease
Valter Niemela et al.
PLOS ONE (2018)
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
Lauren M. Byrne et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Co-occurrence of mixed proteinopathies in late-stage Huntington's disease
Isabelle St-Amour et al.
ACTA NEUROPATHOLOGICA (2018)
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
Lauren M. Byrne et al.
LANCET NEUROLOGY (2017)
Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?
Valter Niemela et al.
PLOS ONE (2017)
Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease
Giulia Cisbani et al.
BRAIN (2017)
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease
Filipe Brogueira Rodrigues et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Cerebrospinal Fluid Biomarkers for Huntington's Disease
Lauren M. Byrne et al.
JOURNAL OF HUNTINGTONS DISEASE (2016)
The role of tau in the pathological process and clinical expression of Huntington's disease
Romina Vuono et al.
BRAIN (2015)
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients
Edward J. Wild et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Mutant huntingtin alters Tau phosphorylation and subcellular distribution
David Blum et al.
HUMAN MOLECULAR GENETICS (2015)
Diagnostic Criteria for Huntington's Disease Based on Natural History
Ralf Reilmann et al.
MOVEMENT DISORDERS (2014)
Huntington's disease is a four-repeat tauopathy with tau nuclear rods
Marta Fernandez-Nogales et al.
NATURE MEDICINE (2014)
Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's Disease
Shea Gluhm et al.
MOVEMENT DISORDERS (2013)
The importance of tau phosphorylation for neurodegenerative diseases
Wendy Noble et al.
FRONTIERS IN NEUROLOGY (2013)
A Comparison of Two Brief Screening Measures of Cognitive Impairment in Huntington's Disease
Laura Mickes et al.
MOVEMENT DISORDERS (2010)
Challenges Assessing Clinical Endpoints in Early Huntington Disease
Jane S. Paulsen et al.
MOVEMENT DISORDERS (2010)
分享论文
